• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: JOHNSON & JOHNSON SURGICAL VISION, INC. TECNIS SYMFONY TORIC; MULTIFOCAL IOLS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

JOHNSON & JOHNSON SURGICAL VISION, INC. TECNIS SYMFONY TORIC; MULTIFOCAL IOLS Back to Search Results
Model Number ZXT225
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Visual Disturbances (2140); Halo (2227); No Code Available (3191)
Date of Event 04/04/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
If explanted, give date: not applicable, as lens remains implanted.Phone number, facility name, address: unknown as event is about a masked clinical study.(b)(4).Other: the device is not returning for evaluation as it remains implanted; therefore, a failure analysis of the complaint device cannot be completed.A review of the device/lot history record, labeling, complaint trending, and risk documentation for this device will be performed.Upon completion of the review, if there is any further relevant information a supplemental medwatch will be filed.All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
 
Event or Problem Description
It was reported that a study patient at the 4th month visit, developed halos/starbursts and reports they have worsened compared to before surgery.It was stated that patient is very bothered of the visual issues, driving at night.Nevertheless, the preoperative monocular best corrected distance visual acuity (bcdva) were 20/25 for right eye (od) and 20/30 for left eye (os).At 4th month visit, visual acuity reported to be 20/40 right eye (od), 20/32 left eye (os).There was no intervention planned.No other information was provided.This mdr report pertains to the left eye (os).A separate report will be submitted for the right eye (od).
 
Additional Manufacturer Narrative
This correction mdr is being submitted to address inaccurate information in section f on the xml version of the previous submission caused by a software glitch in the transmission process.The internal non-conformance numbers for this software issue are nr-0148919 and capa-010215.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TECNIS SYMFONY TORIC
Common Device Name
MULTIFOCAL IOLS
Manufacturer (Section D)
JOHNSON & JOHNSON SURGICAL VISION, INC.
1700 e st andrew place
santa ana CA 92705
MDR Report Key8580816
Report Number9614546-2019-00424
Device Sequence Number11214478
Product Code POE
UDI-Device Identifier05050474605893
UDI-Public(01)05050474605893(17)211102
Combination Product (Y/N)Y
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
P980040
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2018
Reporter Type Manufacturer
Report Source health professional,study,use
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 11/11/2020
Report Date (Section F) 01/01/2005
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date11/02/2021
Device Model NumberZXT225
Device Catalogue NumberZXT225U250
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Report to Manufacturer01/10/2005
Initial Date Received by Manufacturer 04/04/2019
Supplement Date Received by Manufacturer10/25/2020
Initial Report FDA Received Date05/04/2019
Supplement Report FDA Received Date11/12/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Date Report Sent to FDA01/01/2005
-
-